Sources say Baxter's near an agreement with EU regulators in $4B Gambro merger

July 11, 2013 by Sony Salzman

Anonymous sources say that Baxter is nearing an agreement with European Commission anti-trust regulators over the $4 billion acquisition of Swedish dialysis giant Gambro AB.

Baxter proposes fixes to EU’s antitrust concerns

Healthcare giant Baxter (NYSE:BAX) may be on the verge of closing its $4 billion buyout of Swedish dialysis devices maker Gambro AB after offering to divest some of its assets in order to appease European regulators, according to anonymous sources cited by Reuters.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp